Cost of Epilepsy: A Systematic Review

Author： Strzelczyk Adam   Jens Peter Reese   Dodel Richard   Hamer Hajo M.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.26, Iss.6, 2008-01, pp. : 463-476

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost of Illness of Glaucoma: A Critical and Systematic Review

By Fiscella Richard G.  

PharmacoEconomics, Vol. 27, Iss. 3, 2009-01 ,pp. : 189-198

Adis International

Access to resources Recommend Favorite

The Cost Effectiveness of Human Papillomavirus Vaccines: A Systematic Review

By Seto Katherine  

Drugs, Vol. 72, Iss. 5, 2012-03 ,pp. : 715-743

Adis International

Access to resources Recommend Favorite

Cost analyses of remifentanil, mivacurium and ropivacaine – a systematic review

By Vassiliou Timon   Putzke Caroline   Geldner Götz   Eberhart Leopold  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 2, 2004-02 ,pp. : 415-425

Informa Healthcare

Access to resources Recommend Favorite

A systematic review of cost-effectiveness analyses of pharmacogenomic interventions

By Phillips Kathryn A   Van Bebber Stephanie L  

Pharmacogenomics, Vol. 5, Iss. 8, 2004-12 ,pp. : 1139-1149

Future Medicine

Access to resources Recommend Favorite

Effectiveness and Cost of Risperidone and Olanzapine for Schizophrenia: A Systematic Review

By Hargreaves William A.  

CNS Drugs, Vol. 19, Iss. 5, 2005-01 ,pp. : 393-410

Adis International

Access to resources Recommend Favorite